The 12 closest competitors and alternatives to CroiValve among medical devices companies — ranked by similarity to what CroiValve actually does, not by market-cap band.
Subscribe to see CroiValve’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
CroiValve is a Dublin-based medical technology company focused on developing minimally invasive heart valve devices, such as the DUO System, to treat tricuspid regurgitation.
CroiValve is a medical devices company headquartered in Ireland. Xcout tracks 12 named people at CroiValve, including Jaime Wheeler (CEO).
6 more named people on record for CroiValve, with roles, board committees and tenure — see the full roster →
Ranked by semantic similarity — how close each company is to CroiValve by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar medical devices company
Coramaze Technologies is a clinical and pre-commercial stage medical device company founded in 2013, with offices in Germany and Israel. The company is focused on developing an innovative transcatheter tricuspid valve repair system called TriPair.
Similar medical devices company
Trisol Medical is a medical equipment manufacturing company headquartered in Yokneam, Israel. The company specializes in the design and development of medical device concepts aimed at addressing unmet clinical needs in treating Tricuspid Valve insufficiency.
Similar medical devices company
TRiCares is a medical device company with global offices that designs and develops specialized structural heart treatments and catheter-based valve repair systems.
Medical Device
Vivasure Medical is an Irish medical-device company developing the Vivasure PerQseal, a sutureless, absorbable closure device for large-bore femoral vascular access sites. It serves clinicians performing transcatheter cardiovascular and other endovascular procedures, including interventional cardiology and radiology.
Similar medical devices company
Capstan Medical is a medical-device company developing minimally invasive, catheter-based systems for transcatheter mitral valve replacement. Its technology is intended for patients with mitral valve disease and the clinicians who treat them, particularly those who may be at elevated risk for open-heart surgery.
Similar medical devices company
HighLife Medical is a pre-commercial stage medical device company headquartered in Paris, France, with additional facilities in Irvine, California. The company develops trans-septal mitral valve replacement (TSMVR) technologies for treating structural heart disease.
Similar medical devices company
Foldax, Inc. is an award-winning medical device company headquartered in Salt Lake City, Utah. The company specializes in the development and manufacturing of innovative Tria heart valves.
Medical Device
Laguna Tech USA, Inc. is a medical technology company that develops structural heart solutions, specifically focusing on transcatheter aortic valve systems. The company's flagship product, the ZETA Transcatheter Aortic Valve System, is an investigational device designed to treat both aortic regurgitation and aortic stenosis.
Similar medical devices company
WhiteSwell is a clinical-stage medical technology company headquartered in Galway, Ireland. The company pioneers device-based treatments for acute decompensated heart failure by targeting and supporting the human lymphatic system.
Similar medical devices company
Micro Interventional Devices, Inc. is a medical equipment manufacturing company developing novel solutions for structural heart disease treatments like mitral valve repair.
Similar medical devices company
InVera Medical is a medical device company based in the medtech cluster of Galway, Ireland. The company focuses on developing next-generation, less invasive treatment solutions for patients suffering from chronic venous disease.
Similar medical devices company
Jenscare Scientific Co., Ltd. operates as a medical technology enterprise dedicated to advancing interventional therapies for structural heart conditions within the People's Republic of China. Among its pipeline, the company features LuX-Valve, an investigational transcatheter tricuspid valve replacement (TTVR) system designed for patients suffering from severe tricuspid regurgitation who face elevated surgical risks. Additionally, Ken-Valve represents another key product candidate, a transcatheter aortic valve replacement (TAVR) aimed at addressing severe aortic regurgitation, often co-occurring with aortic stenosis. The applications of Jenscare's portfolio extend to a range of structural cardiac maladies, including disorders of the tricuspid, aortic, and mitral valves, as well as heart failure. Founded in 2011, the company maintains its principal place of business in Ningbo, People's Republic of China.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for CroiValveand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →